Home LiteratureArticle Details
PMID: 8507111 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide.

Annals of surgery ·Vol. 217 ·No. 6 ·1993-06-00 ·Pages 644-53; discussion 653-4

Gianotti L, Alexander JW, Pyles T, Fukushima R

Abstract

The effect of arginine on survival rates and host defense mechanisms was studied using two clinically relevant models of infection that included transfusion-induced immunosuppression. Dietary arginine will improve resistance to infection but its role in transfusion-induced immunosuppression and bacterial translocation (gut-derived sepsis) has not been defined. Balb/c mice were fed for 10 days with either a defined AIN-76A diet, an AIN-76A diet supplemented with 2% arginine, an AIN-76A diet supplemented with 4% glycine, or standard laboratory chow. In most experiments, the mice were then transfused with allogeneic blood and allowed to feed for an additional 5 days before undergoing either cecal ligation and puncture (CLP) or gavage with 10(10) Escherichia coli and a 20% burn injury. Additional animals fed with the arginine supplemented diet were treated with the nitric oxide inhibitor N omega-Nitro-L-arginine (NNA) before gavage and burn. The effect of these diets and NNA on the degree of translocation of 14C-radiolabeled E. coli from the intestine and the ability of the host to kill translocated organisms was also investigated. Mice were fed and received transfusion, gavage, and burn as above. Mesenteric lymph nodes (MLN), liver and spleen were harvested 4 hours postburn. Survival after CLP was 56% in the arginine-supplemented group versus 28% in the AIN-76A group and 20% in the chow group (p < 0.02). After gavage and burn, survival was 100% in the arginine-supplemented group versus 50% in both the glycine-supplemented and chow groups and 35% in the AIN-76A group (p < 0.01). In animals receiving the arginine-supplemented diet, treatment with NNA decreased survival from 95% to 30.5% (p < 0.0001). Greater translocation, as measured by radionuclide counts, was observed to the MLN of the AIN-76A group. However, there was no difference in translocation to the liver and spleen related to dietary group. Quantitative colony counts and the calculated percentage of remaining viable bacteria showed that the ability to kill translocated organisms was significantly enhanced in animals receiving arginine. Treatment with NNA reversed the beneficial effects of arginine on immune defense. The benefit of arginine appears to be mediated by improved bactericidal mechanisms via the arginine-nitric oxide pathway.

MeSH Terms
Animals Arginine/administration & dosage,pharmacology Bacteria/metabolism Bacterial Physiological Phenomena Blood Transfusion Burns/microbiology,physiopathology Cecum/microbiology Diet Disease Susceptibility Escherichia coli/physiology Escherichia coli Infections/physiopathology Female Ligation Liver/microbiology Lymph Nodes/microbiology Mice Mice, Inbred BALB C Mice, Inbred C3H Mice, Inbred Strains Nitric Oxide/pharmacology Peritonitis/physiopathology Punctures Spleen/microbiology Survival Rate
Chemicals
Nitric Oxide Arginine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gianotti L
Department of Surgery, University of Cincinatti College of Medicine, Ohio.
Alexander J W
Pyles T
Fukushima R
References (47)
47 references, click to expand
  1. Arginine: an essential amino acid for injured rats.
    Surgery. 1978 Aug;84(2):224-30 PMID: 684614
  2. Reduction of bacterial translocation with oral fibroblast growth factor and sucralfate.
    Am J Surg. 1993 Jan;165(1):195-200; discussion 200-1 PMID: 8418697
  3. Determination of immunoreactive somatostatin in rat plasma and responses to arginine, glucose and glucagon infusion.
    Diabetologia. 1979 Nov;17(5):319-23 PMID: 499688
  4. Immunostimulatory effects of arginine in normal and injured rats.
    J Surg Res. 1980 Sep;29(3):228-35 PMID: 6968002
  5. Arginine stimulates lymphocyte immune response in healthy human beings.
    Surgery. 1981 Aug;90(2):244-51 PMID: 7020137
  6. A study of growth hormone release in man after oral administration of amino acids.
    Curr Med Res Opin. 1981;7(7):475-81 PMID: 6790230
  7. Plasma growth hormone after arginine infusion. Clinical experiences.
    N Engl J Med. 1967 Feb 23;276(8):434-9 PMID: 4164428
  8. Polyamine synthesis during lymphocyte activation. Induction of ornithine decarboxylase and S-adenosyl methionine decarboxylase.
    Exp Cell Res. 1973 Mar 15;77(1):428-36 PMID: 4120440
  9. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.
    J Infect Dis. 1975 Jun;131(6):688-91 PMID: 805812
  10. Contributions of bile and pancreatic juice to cell proliferation in ileal mucosa.
    Surgery. 1978 May;83(5):570-6 PMID: 644449
  11. Metabolic and immune effects of arginine in postinjury hyperalimentation.
    J Trauma. 1981 Nov;21(11):970-4 PMID: 6795362
  12. High arginine levels in intravenous hyperalimentation abrogate post-traumatic immune suppression.
    J Surg Res. 1984 Jun;36(6):620-4 PMID: 6427525
  13. Mechanism of prevention of postburn hypermetabolism and catabolism by early enteral feeding.
    Ann Surg. 1984 Sep;200(3):297-310 PMID: 6431918
  14. Evaluation of the effect of arginine-enriched amino acid solution on tumor growth.
    JPEN J Parenter Enteral Nutr. 1985 Jul-Aug;9(4):428-34 PMID: 3928915
  15. Effect of transfusion on immune function in a traumatized animal model.
    Arch Surg. 1986 Jan;121(1):50-5 PMID: 3484624
  16. Multiple-organ-failure syndrome.
    Arch Surg. 1986 Feb;121(2):196-208 PMID: 3484944
  17. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells.
    J Immunol. 1987 Jan 15;138(2):550-65 PMID: 2432129
  18. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.
    Science. 1987 Jan 23;235(4787):473-6 PMID: 2432665
  19. Metabolic and immune effects of dietary arginine supplementation after burn.
    Arch Surg. 1987 Jul;122(7):784-9 PMID: 3109352
  20. The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU.
    Ann Surg. 1987 Oct;206(4):427-48 PMID: 3116956
  21. Stimulation of T cell immunity by arginine enhances survival in peritonitis.
    J Surg Res. 1988 Jun;44(6):658-63 PMID: 3259997
  22. Immunomodulatory mechanisms of arginine.
    Surgery. 1988 Aug;104(2):142-51 PMID: 2840748
  23. Immune and metabolic effects of arginine in the surgical patient.
    Ann Surg. 1988 Oct;208(4):512-23 PMID: 3140744
  24. The role of intestinal endotoxin in experimental peritonitis.
    Circ Shock. 1989 Jan;27(1):83-91 PMID: 2917375
  25. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.
    Biochemistry. 1988 Nov 29;27(24):8706-11 PMID: 3242600
  26. Simple intestinal obstruction causes bacterial translocation in man.
    Arch Surg. 1989 Jun;124(6):699-701 PMID: 2730322
  27. Genetic susceptibility to mucosal damage leads to bacterial translocation in a murine burn model.
    J Trauma. 1989 Sep;29(9):1245-51 PMID: 2769809
  28. Does the bacteremia observed in hemorrhagic shock have clinical significance? A study in germ-free animals.
    Ann Surg. 1989 Sep;210(3):342-5; discussion 346-7 PMID: 2774708
  29. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.
    J Natl Cancer Inst. 1990 May 2;82(9):772-6 PMID: 2109093
  30. Intraabdominal infections and gut origin sepsis.
    World J Surg. 1990 Mar-Apr;14(2):191-5 PMID: 2183481
  31. Arginine supplementation and its effect on established peritonitis in guinea pigs.
    JPEN J Parenter Enteral Nutr. 1990 May-Jun;14(3):237-44 PMID: 2112635
  32. An experimental assessment of the effect of blood transfusion on susceptibility to bacterial infection.
    Surgery. 1990 Sep;108(3):567-71 PMID: 2396200
  33. The process of microbial translocation.
    Ann Surg. 1990 Oct;212(4):496-510; discussion 511-2 PMID: 2222015
  34. Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage.
    J Leukoc Biol. 1990 Dec;48(6):565-9 PMID: 2230601
  35. Distribution and survival of Escherichia coli translocating from the intestine after thermal injury.
    Ann Surg. 1991 Jun;213(6):558-66; discussion 566-7 PMID: 2039286
  36. Stimulation of proximal small intestinal mucosal growth by luminal polyamines.
    Am J Physiol. 1991 Sep;261(3 Pt 1):G504-11 PMID: 1716059
  37. Endogenous nitric oxide: physiology, pathology and clinical relevance.
    Eur J Clin Invest. 1991 Aug;21(4):361-74 PMID: 1718757
  38. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
    Lancet. 1991 Dec 21-28;338(8782-8783):1555-7 PMID: 1683974
  39. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
    Lancet. 1991 Dec 21-28;338(8782-8783):1557-8 PMID: 1720856
  40. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.
    J Clin Invest. 1992 Mar;89(3):867-77 PMID: 1541678
  41. Enhancement of interleukin-2 immunotherapy with L-arginine.
    Ann Surg. 1992 Feb;215(2):157-65 PMID: 1546902
  42. Impact of blood transfusion and burn injury on microbial translocation and bacterial survival.
    Transfusion. 1992 May;32(4):312-7 PMID: 1585434
  43. Overproduction of nitric oxide in cytokine-mediated and septic shock.
    J Natl Cancer Inst. 1992 Jun 3;84(11):827-31 PMID: 1375655
  44. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome.
    Surgery. 1992 Jul;112(1):56-67 PMID: 1377838
  45. The degree of bacterial translocation is a determinant factor for mortality after burn injury and is improved by prostaglandin analogs.
    Ann Surg. 1992 Oct;216(4):438-44; discussion 444-5 PMID: 1417193
  46. Arginine enhances T-cell responses in athymic nude mice.
    JPEN J Parenter Enteral Nutr. 1992 Sep-Oct;16(5):429-32 PMID: 1433776
  47. Microenvironmental arginine depletion by macrophages in vivo.
    Br J Cancer. 1979 Jun;39(6):613-20 PMID: 444403
Article Info
Journal
Annals of surgery
Abbr.
Ann Surg
ISSN
0003-4932
Published
1993-06-00
Pages
644-53; discussion 653-4
Language
English
Region
United States
NLM ID
0372354
PMCID
PMC1242869
Subset
IM
Grants
NIAID NIH HHS · AI-12936 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]